Drugs / EndostarTM
last change Jul 2018 re-read 2 minutes ago

EndostarTM

Developed for
breast cancer
Investigated by
Xinjiang Medical University

Trials 1 · a red edge is where a trial was stopped

20162017201820192020202120222023202420252026
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT02489409 Oct 2015 → May 2018 breast cancer Xinjiang Medical University Unknown No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as EndostarTM ClinicalTrials.gov intervention name — accepted as the source's own label NCT02489409